Stockscreener 앱 받기
5.04
2.33%
-0.12
시간 외 거래:
5.25
0.21
+4.17%
Personalis Inc 주식(PSNL)의 최신 뉴스
Personalis reiterates 2025 revenue guidance of $80M-$90M with focus on MRD testing growth - MSN
HC Wainwright Raises Personalis (NASDAQ:PSNL) Price Target to $9.00 - Defense World
Companies Like Personalis (NASDAQ:PSNL) Are In A Position To Invest In Growth - Yahoo Finance
Barclays PLC Acquires 43,900 Shares of Personalis, Inc. (NASDAQ:PSNL) - The AM Reporter
JPMorgan Chase & Co. Has $34,000 Position in Personalis, Inc. (NASDAQ:PSNL) - Defense World
Barclays PLC Increases Stock Holdings in Personalis, Inc. (NASDAQ:PSNL) - Defense World
Personalis stock price target raised to $9 at H.C. Wainwright By Investing.com - Investing.com Australia
Personalis Inc.: Strong Financial Performance and Promising Future Prospects Drive Buy Rating - TipRanks
Will Personalis' Testing Growth And MRD Strategy Pay Off In 2025? - Nasdaq
Analyst Expectations For Personalis's Future - Benzinga
Personalis, Inc. (NASDAQ:PSNL) Q1 2025 Earnings Call Transcript - Insider Monkey
Personalis (PSNL) Receives Price Target Boost from Analyst | PSNL Stock News - GuruFocus
H.C. Wainwright Increases Price Target for Personalis (PSNL) to $9 | PSNL Stock News - GuruFocus
Personalis Reports Strong Q1 Growth in Genomics - TipRanks
Personalis Inc (PSNL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... - Yahoo Finance
Earnings call transcript: Personalis beats Q1 2025 earnings, stock rises By Investing.com - Investing.com South Africa
Personalis Inc (PSNL) Q1 2025 Earnings Call Highlights: Strong R - GuruFocus
Personalis Reports First Quarter 2025 Financial Results - BioSpace
Personalis: Q1 Earnings Snapshot - CTPost
Personalis (PSNL) Q1 2025 Earnings Reflects Strong Growth in Molecular Tests - GuruFocus
Personalis (PSNL) Q1 2025 Earnings Reflects Strong Growth in Mol - GuruFocus
Earnings call transcript: Personalis beats Q1 2025 earnings, stock rises - Investing.com
Personalis (PSNL) Reports Strong Q1 Revenue and Testing Growth | - GuruFocus
Personalis Inc (PSNL) Q1 2025 Earnings: EPS of -$0.24 Beats Esti - GuruFocus
Personalis (PSNL) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Personalis Inc (PSNL) Q1 2025 Earnings: EPS of -$0.24 Beats Estimate, Revenue at $13.6M Misses Estimate - GuruFocus
PSNL Projects Diverse Revenue Streams Across Multiple Segments | PSNL Stock News - GuruFocus
Personalis, Inc. (NASDAQ:PSNL) Stocks Shoot Up 37% But Its P/S Still Looks Reasonable - simplywall.st
Invesco Ltd. Invests $82,000 in Personalis, Inc. (NASDAQ:PSNL) - Defense World
Personalis Inc (PSNL) Q1 2025 Earnings Report Preview: What To E - GuruFocus
Personalis Inc (PSNL) Q1 2025 Earnings Report Preview: What To Expect - GuruFocus
Personalis Inc (PSNL) Performance and Fundamentals Dashboard tells a completely different story - Sete News
Market Momentum Report: Personalis Inc (PSNL)’s Negative Close at 3.78 - DWinneX
Results from Personalis Inc (PSNL) show potential - uspostnews.com
Examining the Potential Price Growth of Personalis Inc (PSNL) - knoxdaily.com
Personalis (PSNL) Reveals Promising Interim Results in Colorecta - GuruFocus
Personalis’ NeXT Personal® Detects 100% of Colorectal Cancer Relapses Ahead of Imaging in VICTORI Cancer Study - BioSpace
Personalis' NeXT Personal® Detects 100% of Colorectal Cancer Rel - GuruFocus
Investor’s Delight: Personalis Inc (PSNL) Closes Weak at 4.14, Down -1.90 - DWinneX
Gaining Ground: Personalis Inc (PSNL) Closes Lower at 3.51, Down -3.04 - DWinneX
PSNL Stock Sees Surge of Approximately 12.88% in Last Five Days - knoxdaily.com
Several Personalis Insiders Sell Shares Sending Potential Negative Signal - simplywall.st
Personalis and Academic Partners to Present Latest Data on UltraNORTHEAST - NORTHEAST - NEWS CHANNEL NEBRASKA
Personalis Inc (PSNL) produces promising results - uspostnews.com
Personalis to Announce First Quarter 2025 Financial Results - BioSpace
Is Personalis, Inc. (PSNL) the Best Multibagger Penny Stock to Buy According to Billionaires? - Insider Monkey
10 Best Multibagger Penny Stocks to Buy According to Billionaires - Insider Monkey
Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Test for Residual Cancer and Recurrence Detection | PSNL Stock News - GuruFocus
Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Test for Residual Cancer and Recurrence Detection - Business Wire
LPL Financial LLC Sells 6,773 Shares of Personalis, Inc. (NASDAQ:PSNL) - Defense World
Renaissance Technologies LLC Trims Stock Position in Personalis, Inc. (NASDAQ:PSNL) - Defense World
PSNL Stock Sees Decline of Approximately -2.66% in Last Five Days - knoxdaily.com
Arrowstreet Capital Limited Partnership Lowers Stock Holdings in Personalis, Inc. (NASDAQ:PSNL) - Defense World
0.60%
1.22%
자본화:
|
볼륨(24시간):